PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway ; volume:15 ; number:3 ; day:12 ; month:4 ; year:2024 ; pages:1-14 ; date:3.2024
Cell death & disease ; 15, Heft 3 (12.4.2024), 1-14, 3.2024
- Creator
-
Ma, Yuanzhen
Fang, Zhiyu
Zhang, Hongning
Qi, Yijun
Mao, Yuke
Zheng, Junfang
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41419-024-06502-2
- URN
-
urn:nbn:de:101:1-2405112127541.081287695876
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ma, Yuanzhen
- Fang, Zhiyu
- Zhang, Hongning
- Qi, Yijun
- Mao, Yuke
- Zheng, Junfang
- SpringerLink (Online service)
Other Objects (12)
Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR
EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis
Inhibition of ABI2 ubiquitination-dependent degradation suppresses TNBC cell growth via down-regulating PI3K/Akt signaling pathway
Unrevealing the Role of miRNA in Successful TNBC Treatment: A Pilot Study to Explore the Chemotherapy Drugs for Timely Treatment of TNBC
The Potential of PSMA as a Vascular Target in TNBC
FZD5 contributes to TNBC proliferation, DNA damage repair and stemness
Hypoxia‐Induced FUS–circTBC1D14 Stress Granules Promote Autophagy in TNBC
Differential gene expression analysis of palbociclib-resistant TNBC via RNA-seq
The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)
TAZ maintains telomere length in TNBC cells by mediating Rad51C expression
Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34
Chemotherapeutic stress influences EMT and stemness in cancer stem cells of TNBC
Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR
EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis
Inhibition of ABI2 ubiquitination-dependent degradation suppresses TNBC cell growth via down-regulating PI3K/Akt signaling pathway
Unrevealing the Role of miRNA in Successful TNBC Treatment: A Pilot Study to Explore the Chemotherapy Drugs for Timely Treatment of TNBC
The Potential of PSMA as a Vascular Target in TNBC
FZD5 contributes to TNBC proliferation, DNA damage repair and stemness
Hypoxia‐Induced FUS–circTBC1D14 Stress Granules Promote Autophagy in TNBC
Differential gene expression analysis of palbociclib-resistant TNBC via RNA-seq
The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)
TAZ maintains telomere length in TNBC cells by mediating Rad51C expression
Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34
Chemotherapeutic stress influences EMT and stemness in cancer stem cells of TNBC
Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR
EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis
Inhibition of ABI2 ubiquitination-dependent degradation suppresses TNBC cell growth via down-regulating PI3K/Akt signaling pathway
Unrevealing the Role of miRNA in Successful TNBC Treatment: A Pilot Study to Explore the Chemotherapy Drugs for Timely Treatment of TNBC
The Potential of PSMA as a Vascular Target in TNBC
FZD5 contributes to TNBC proliferation, DNA damage repair and stemness
Hypoxia‐Induced FUS–circTBC1D14 Stress Granules Promote Autophagy in TNBC
Differential gene expression analysis of palbociclib-resistant TNBC via RNA-seq
The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)
TAZ maintains telomere length in TNBC cells by mediating Rad51C expression
Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34